Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Intervention1: C.Palmitole,T.Carbamazepine: C.Palmitole 354 mg BD + T.Carbamazepine 200mg OD for 12weeks
Control Intervention1: T.Carbamazepine: T.Carbamazepine 200mg-OD for 12 weeks
Sponsors
Government Kilpauk Medical College
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed with neuropathy using diagnostic tests (Tip-Therm test, Monofilament test, Biothesiometry) at the Diabetology Clinic in our hospital Participants exhibiting neuropathic pain scoring more than 4 on Neuropathic Pain Diagnostic Questionnaire(DN4) and scoring more than 12 on S-LANSS (Self reported Leeds Assessment of Neuropathic Symptoms and Signs(S-LANSS)
Exclusion criteria
Exclusion criteria: Participants with Type1 diabetes mellitus, not willing to participant,pregnant and lactating mothers, history of hypersensitivity,those who are on longterm steroid, those wtih documented history of other neuropathies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diabetic Neuropathy pain score assesed using BPI-DPN Pain scale with FBS,PPBSTimepoint: at Baseline,4,8,12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Participants will be assessed clinically by Tip-Therm test, Monofilament test, Biothesiometr,CBC, RFT, LFT, Lipid profileTimepoint: At baseline and at 12 weeks | — |
Countries
India
Contacts
Public ContactDr Viswanath S
Tamilnadu Dr MGR Medical university
Outcome results
None listed